The trial found that adding 8,000 milligrams of the antibody cocktail to usual care reduced the risk of death by 20 percent in hospitalized COVID-19 patients who had not mounted their own immune response against the virus.
The FDA granted emergency use authorization to the antibody cocktail in November. Regeneron said it will discuss the new data with regulatory authorities immediately and request the treatment’s FDA emergency use authorization be expanded to include appropriate hospitalized patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
